To match innovators with a task force of experts to develop commercially-viable products and services with the greatest potential for societal and economic impact in Europe this time European Institute of Innovation and Technology (EIT Health) joined forces with Amgen, Bayer, Beiersdorf AG, and Boehringer Ingelheim.
AMGEN, one of the world’s leading biotechnology companies, aimed at finding the solution to create a standardized procedure for post-MI patients after discharge, pointing out that preventing myocardial infarction (MI) in a population at risk and in patients who have already experienced an MI episode is extremely important.
Particularly, AMGEN was looking for a predictive analytics tool to identify very high-risk patients and a procedure/tool which will provide holistic support to post-MI patients after discharge.
Cardiolyse provides exactly the platform for accurate and complex remote cardiac patients monitoring with the proprietary algorithms on heart failure risk stratification.
We're excited by the delivered innovation and entrepreneurship workshops and are looking forward to furthering program collaborations!
Cardiolyse is selected for the AMGEN Challenge of 2020 EIT Health Startups Meet Pharma event
Read more

Cardiolyse crowdfunding open on Aescuvest.de
Happy to announce we’ve just opened a crowdfunding campaign on the Aescuvest platform! We’ve been looking forward to this day as it gives us all opportunity to shape the future of Cardiovascular Health together! Aescuvest is the first pan-European digital venture capital platform in the healthcare space, dedicated to actively shaping the future of health in Europe and we are happy to be […]
Read more
Cardiolyse shows a successful pilot project at EXPO 6 Startup Creasphere by Plug and Play
As a result of a 3-months accelerator program Cardiolyse showcased the outcome of our pilot at Munich Summer Summit. Startup Creasphere: Established in 2018 by Roche Diagnostics and Plug and Play, Startup Creasphere is the first healthcare-focused innovation platform in Munich. Startup Creasphere creates an environment within the global network of Plug and Play where corporations and startups learn and […]
Read more
EIT Health Catapult 2021 selects Cardiolyse for the semi-final
We will receive intensive training from experts, meet investors and corporates, and compete in pitch contests to progress to the finals. The EIT Health Catapult, currently in its sixth year, is a training and competition programme that boosts the development of European health start-ups by exposing them to top-quality experts and international investors. The programme has already supported over 189 start-ups […]
Read more
Cardiolyse is chosen for the first edition of the Health&Biotech accelerator by Deloitte Italy
Cardiolyse is one of 6 international startups chosen among over 350 applicants, that will participate in the Health&BioTech Accelerator’s program coordinated by Deloitte Officine Innovazione in collaboration with MSD Italia, Intesa Sanpaolo RBM Salute, and some of the largest private healthcare providers in the Country such as Gruppo San Donato. The initiative is also supported by the clinical partners Humanitas and Santagostino, by the Italian Institue of […]
Read more
Startup Creasphere by Plug and Play selects Cardiolyse for their 3-months-program
Startup Creasphere, Europe’s largest healthcare innovation platform kicks off Batch 6. The corporate partners selected 17 startups for the 3-months-program and Cardiolyse is one of the winners! A total of 38 applications were received from a wide range of organisations across Europe. For the next 3 months, we’ll be working on co-creation with a corporate partner, receiving coaching and mentoring, […]
Read more
Let’s work together
on heart health improvement